Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Bevacizumab|DRUG: Cyclophosphamide|DRUG: Docetaxel
Sponsor: University of Arkansas
Collaborators: Genentech, Inc.